1-17 of 17
Supriya Gupta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of real-world survival outcomes and time toxicity of CAR T-cell versus bispecific antibody therapies in relapsed/refractory follicular lymphoma: A multicenter cohort from 15 US academic institutions

Free
Ajay Major, Diana Abbott, Jordan Snyder, Nausheen Ahmed, Alline Amorim, Jose Villasboas Bisneto, John Sharp, Timothy Voorhees, Samin Houshyar, Danielle Wallace, Arjab Adhikari, Dilan Patel, Christopher Wanjiku, Charlotte Wagner, Allison Bock, Taylor Brooks, Haya Al Any, Mazie Tsang, Mohamed Rajab, Madiha Iqbal, Nidhi Desai, Supriya Gupta, Nicole Altomare, Reem Karmali, Daniel Trotier, Priyanka Pophali, Edd Ricker, Hua-Jay Cherng, Arjun Gupta, Brian Hill
Journal: Blood
Blood (2025) 146 (Supplement 1): 1798.
https://doi.org/10.1182/blood-2025-1798
Published: 2025
Journal Articles

A post-marketing pharmacovigilance analysis of cardiotoxicities following chimeric antigen receptor T-cell therapy using the FDA adverse event reporting system

Free
Malvika Gupta, Supriya Gupta, Christopher Graham
Journal: Blood
Blood (2025) 146 (Supplement 1): 6301.
https://doi.org/10.1182/blood-2025-6301
Published: 2025
Journal Articles

Activity of autologous anti-CD19 chimeric antigen receptor T-cell therapy in CD19-negative large B-cell lymphoma: A cell therapy consortium real world experience

Free
Chen Zhang, Xiaowen Sun, Lei Feng, David Porter, Stephen J. Schuster, Olalekan Oluwole, Veronika Bachanova, Supriya Gupta, Joseph McGuirk, Richard Maziarz, Andy Chen, Sairah Ahmed, Peter Riedell, Anthony Hunter, Paolo Strati
Journal: Blood
Blood (2025) 146 (Supplement 1): 957.
https://doi.org/10.1182/blood-2025-957
Published: 2025
Journal Articles

Incidence and risk factors of chronic kidney disease (CKD) in lymphoma survivors

Free
Nidhi Desai, Ryan Shanley, Sunil Rao, Marie Hu, Veronika Bachanova, Supriya Gupta, Sean Tracy, Anne Blaes, Sanjal Desai
Journal: Blood
Blood (2025) 146 (Supplement 1): 2754.
https://doi.org/10.1182/blood-2025-2754
Published: 2025
Journal Articles

Novel composite end-points toxicity/progression-free survival (tfPFS) and toxicity-free complete remission (tfCR100) after CAR-T cell therapy for diffuse large B cell lymphoma: Cell therapy consortium analysis.

Free
Veronika Bachanova, Qing Cao, Marie Hu, Supriya Gupta, Miguel-Angel Perales, Olalekan Oluwole, Richard Maziarz, Joseph McGuirk, Andy Chen, Stephen J. Schuster, Gunjan Shah, Anthony Hunter, Jamie Brower, David Porter, Peter Riedell
Journal: Blood
Blood (2025) 146 (Supplement 1): 400.
https://doi.org/10.1182/blood-2025-400
Published: 2025
Journal Articles

Real-world effectiveness and safety outcomes by age, comorbidities, and frailty among relapsed or refractory (R/R) Mantle Cell Lymphoma (MCL) patients treated with brexucabtagene autoleucel (brexu-cel)

Free
Amer Beitinjaneh, Supriya Gupta, Fateeha Furqan, John Baird, Wen-Kai Weng, Caron Jacobson, Soyoung Kim, Zhongyu Feng, Babatunde Adedokun, Jiali Yan, Qian Huang, Kenny Hu, Timothy Best, Ioana Kloos, Grace Lee, Mehdi Hamadani, Marcelo Pasquini, Frederick Locke
Journal: Blood
Blood (2025) 146 (Supplement 1): 3606.
https://doi.org/10.1182/blood-2025-3606
Published: 2025
Journal Articles

Azer-cel, an allogeneic (allo) CD19 CAR T, in combination with low-dose interleukin-2 (IL-2) demonstrates clinical activity in patients with large B-cell lymphoma (LBCL) who relapsed after autologous (auto) CAR T

Free
Supriya Gupta, Edmund Waller, Ran Reshef, Vinay Vanguru, Adam Olszewski, Scott Solomon, Joseph Maakaron, Aparna Raval, Sharon Yavrom, John Byon, Bijal Shah
Journal: Blood
Blood (2025) 146 (Supplement 1): 267.
https://doi.org/10.1182/blood-2025-267
Published: 2025
Journal Articles

The Role of Intensive Chemotherapy and Radiotherapy in Plasmablastic Lymphoma: Optimizing Survival Outcomes

Free
Philip A Haddad, Jaren Lerner, Ankita Gupta, Supriya Gupta
Journal: Blood
Blood (2024) 144 (Supplement 1): 3084.
https://doi.org/10.1182/blood-2024-194085
Published: 2024
Journal Articles

Prescriber Preference in Treatment of Relapsed or Refractory Multiple Myeloma (MM) and Diffuse Large B-Cell Lymphoma (DLBCL)

Free
Supriya Gupta, Lay She Ng, Javier L. Munoz, N. Nora Bennani, Arushi Khurana, Jonas Paludo, Joselle Cook, Taxiarchis Kourelis, Nadine Abdallah, Jose C. Villasboas Bisneto, Yucai Wang, Paul J. Hampel, Morie A. Gertz, Rahma M Warsame, Suzanne R Hayman, Madiha Iqbal, Nelson Leung, Prashant Kapoor, Shaji Kumar, David Dingli, Patrick B. Johnston, Stephen M. Ansell, Yi Lin, Urshila Durani
Journal: Blood
Blood (2024) 144 (Supplement 1): 7589.
https://doi.org/10.1182/blood-2024-210586
Published: 2024
Journal Articles

Cytokine Profile Comparisons Among Cytokine Release Syndrome (CRS), Macrophage Activation-like Syndrome (MAS-L) and Immune Effector Cell-Associated Hemophagocytic Syndrome (IEC-HS) in CAR-T Therapy

Free
Supriya Gupta, Andre Corraes, Hassan B Alkhateeb, Alice Gallo de Moraes, Paschalis Vergidis, Radhika Bansal, Saad S. Kenderian, Urshila Durani, Jonas Paludo, Arushi Khurana, Joselle Cook, N. Nora Bennani, Jose C. Villasboas Bisneto, Mithun V Shah, Taxiarchis Kourelis, Nadine Abdallah, Yucai Wang, Morie A. Gertz, Rahma M Warsame, Suzanne R Hayman, Prashant Kapoor, Stephen M. Ansell, Shaji Kumar, David Dingli, Tyler B. Sandahl, Adrienne N. Nedved, Jason Barreto, Robert C Wolf, Patrick B. Johnston, Yi Lin, Nelson Leung
Journal: Blood
Blood (2024) 144 (Supplement 1): 7165.
https://doi.org/10.1182/blood-2024-211111
Published: 2024
Journal Articles

Frailty-Based Outcomes with Bispecific Antibodies in Older Patients with Multiple Myeloma

Free
Nadine Abdallah, Matthew Rees, Supriya Gupta, Mohammed Elhaj, Radhika Bansal, Terri Menser, Gavin Schaeferle, Joselle Cook, Taxiarchis Kourelis, Rahma M Warsame, Wilson I. Gonsalves, Prashant Kapoor, Francis Buadi, Suzanne R Hayman, David Dingli, Morie A. Gertz, Yi Lin, Shaji Kumar
Journal: Blood
Blood (2024) 144 (Supplement 1): 4695.
https://doi.org/10.1182/blood-2024-211768
Published: 2024
Journal Articles

Plasmablastic Lymphoma Descriptors and Clinicopathologic Determinants of Survival: Analysis of a Pooled Database

Free
Philip A Haddad, Jaren Lerner, Supriya Gupta
Journal: Blood
Blood (2023) 142 (Supplement 1): 1755.
https://doi.org/10.1182/blood-2023-180327
Published: 2023
Journal Articles

Fluid-Overload Associated Large B-Cell Lymphoma Clinicopathologic Features and Determinants of Outcomes: Analysis of a Pooled Database

Free
Christopher Graham, Supriya Gupta, Philip A Haddad
Journal: Blood
Blood (2023) 142 (Supplement 1): 6320.
https://doi.org/10.1182/blood-2023-174337
Published: 2023
Journal Articles

Double/Triple Hit Lymphoma Descriptors and Clinicopathologic Determinants of Survival: Analysis of a Pooled Database

Free
Philip A Haddad, Supriya Gupta, Ankita Gupta, Christopher Graham
Journal: Blood
Blood (2023) 142 (Supplement 1): 6298.
https://doi.org/10.1182/blood-2023-182479
Published: 2023
Journal Articles

Primary Effusion Lymphoma (PEL) and Primary Effusion-like Lymphoma (PEL-LL): A Comparative Study of Clinicopathologic Features and Outcomes

Free
Supriya Gupta, Christopher Graham, Philip A Haddad
Journal: Blood
Blood (2023) 142 (Supplement 1): 4477.
https://doi.org/10.1182/blood-2023-174336
Published: 2023
Journal Articles

Primary Cutaneous Gamma-Delta T-Cell Lymphoma (PCGDTCL) Descriptors and Clinicopathologic Determinants of Survival: Analysis of a Pooled Database

Free
Supriya Gupta, Philip A Haddad
Journal: Blood
Blood (2022) 140 (Supplement 1): 3691.
https://doi.org/10.1182/blood-2022-157407
Published: 2022
Journal Articles

Splenic Diffuse Red Pulp Small B-Cell Lymphoma Descriptors and Clinicopathologic Determinants of Clinical Outcomes: Analysis of a Pooled Database

Free
Supriya Gupta, Christopher Graham, Philip A Haddad
Journal: Blood
Blood (2022) 140 (Supplement 1): 3632.
https://doi.org/10.1182/blood-2022-168197
Published: 2022